10x Genomics, Inc.
TXG
$12.81
$0.504.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.72% | 40.58% | 28.41% | 18.27% | -39.17% |
| Total Depreciation and Amortization | -10.42% | -9.61% | 0.20% | 11.06% | 22.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.87% | -21.89% | -19.34% | -10.09% | -3.13% |
| Change in Net Operating Assets | -160.30% | 110.70% | -92.77% | 203.29% | 150.63% |
| Cash from Operations | 961.12% | 311.74% | 143.85% | 243.84% | 32.34% |
| Capital Expenditure | 58.83% | 75.77% | 74.50% | 84.54% | 76.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -173.74% | -147.50% | -111.11% | -74.12% | -59.32% |
| Cash from Investing | -243.04% | -286.84% | -124.44% | -63.24% | -18.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -46.90% | -48.20% | -43.98% | -36.36% | -1.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.90% | -48.20% | -20.16% | -8.02% | 51.35% |
| Foreign Exchange rate Adjustments | 711.86% | 98.10% | -396.97% | 29.08% | -141.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.47% | 33.11% | -111.53% | 13.98% | -0.19% |